The Oncology Institute, Inc. (TOI) has expanded rapidly since its inception in 2007, evolving from a regional player in community oncology to a national leader operating over 60 physician-owned clinics and managing about 2 million patients under value-based contracts. Despite top-line growth powered by population health management contracts across multiple states, the company continues to report significant operating and net losses, reflecting high costs of scaling and risk management complexities inherent in oncology care. TOI’s future growth relies on deepening value-based relationships with payors and expanding clinic capacity, but liquidity constraints and reimbursement risks pose ongoing challenges. Monitoring milestone profitability targets for 2026 and operational improvements will be critical to assessing TOI’s path toward sustainable cash flow generation.